Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: A pilot study by CapLC-ESI-Q-TOF

被引:58
作者
Casado, Begona [1 ,2 ]
Ladarola, Paolo [1 ]
Pannell, Lewis K. [3 ]
Luisetti, Maurizio [4 ]
Corsico, Angelo [4 ]
Ansaldo, Elena [4 ]
Ferrarotti, Ilaria [4 ]
Boschetto, Piera [5 ]
Baraniuk, James N. [2 ]
机构
[1] Univ Pavia, Dipartimento Biochim A Castellani, I-27100 Pavia, Italy
[2] Georgetown Univ, Proteom Lab, Div Rheumatol Immunol & Allergy, Washington, DC 20057 USA
[3] Univ S Alabama, Inst Canc Res, Mobile, AL 36688 USA
[4] Univ Pavia, Fdn IRCCS Policlin San Matteo, Clin Malattie Apparato Resp, Lab Biochim & Genet, I-27100 Pavia, Italy
[5] Univ Ferrara, Sez Igiene & Med Lavoro, Dipartimento Med Clin & Sperimentale, I-44100 Ferrara, Italy
关键词
COPD; chronic bronchitis; smokers; sputum; LC-Q-TOF;
D O I
10.1021/pr070440q
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The current report describes the use of CapLC-ESI-Q/TOF-MS for investigating the proteome profiles of hypertonic saline-induced sputum samples from 56 smokers. The severity of their lung disease ranged from normal (healthy smokers) to chronic bronchitis, chronic obstructive pulmonary disease (COPD), and COPD with emphysema. This pilot study examined the hypothesis that there were distinct differences in protein expression profiles that were related to the phenotype and cigarette smoking illness severity. A total of 203 unique proteins were identified. These may represent the most highly expressed proteins in induced sputum. Our results provide evidence that different proteins are expressed, as the disease progresses from health to more advanced stages, and support our contention that a proteomic approach would be beneficial in discovering selective molecules linked to specific COPD stages.
引用
收藏
页码:4615 / 4623
页数:9
相关论文
共 58 条
[1]   NEUTROPHIL ELASTASE INCREASES SECRETORY LEUKOCYTE PROTEASE INHIBITOR TRANSCRIPT LEVELS IN AIRWAY EPITHELIAL-CELLS [J].
ABBINANTENISSEN, JM ;
SIMPSON, LG ;
LEIKAUF, GD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (03) :L286-L292
[2]   Pulmonary biomarkers in chronic obstructive pulmonary disease [J].
Barnes, Peter J. ;
Chowdhury, Badrul ;
Kharitonov, Sergei A. ;
Magnussen, Helgo ;
Page, Clive P. ;
Postma, Dirkje ;
Saetta, Marina .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (01) :6-14
[3]   Genetics and pulmonary medicine - 9 - Molecular genetics of chronic obstructive pulmonary disease [J].
Barnes, PJ .
THORAX, 1999, 54 (03) :245-252
[4]   Medical progress: Chronic obstructive pulmonary disease. [J].
Barnes, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :269-280
[5]   New treatments for COPD [J].
Barnes, PJ .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (06) :437-446
[6]   Host defense in oral and airway epithelia: chromosome 20 contributes a new protein family [J].
Bingle, CD ;
Gorr, SU .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (11) :2144-2152
[7]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[8]   Association between markers of emphysema and more severe chronic obstructive pulmonary disease [J].
Boschetto, P. ;
Quintavalle, S. ;
Zeni, E. ;
Leprotti, S. ;
Potena, A. ;
Ballerin, L. ;
Papi, A. ;
Palladini, G. ;
Luisetti, M. ;
Annovazzi, L. ;
Iadarola, P. ;
De Rosa, E. ;
Fabbri, L. M. ;
Mapp, C. E. .
THORAX, 2006, 61 (12) :1037-1042
[9]   S100A8 chemotactic protein is abundantly increased, but only a minor contributor to LPS-induced, steroid resistant neutrophilic lung inflammation in vivo [J].
Bozinovski, S ;
Cross, M ;
Vlahos, R ;
Jones, JE ;
Hsuu, K ;
Tessier, PA ;
Reynolds, EC ;
Hume, DA ;
Hamilton, JA ;
Geczy, CL ;
Anderson, GP .
JOURNAL OF PROTEOME RESEARCH, 2005, 4 (01) :136-145
[10]   Identification of human nasal mucous proteins using proteomics [J].
Casado, B ;
Pannell, LK ;
Iadarola, P ;
Baraniuk, JN .
PROTEOMICS, 2005, 5 (11) :2949-2959